Resources Library by ANA

Acceptance of a new product relies upon communication. As an example: Introducing of disposables in French hospitals

The purpose of this paper is to show the lesson a manufacturer of disposables can learn from a study and how he used its results in a concrete way to communicate with the decision makers in order to promote his products. This shall be the object of...

Catalogue: Seminar 1973: Communication And Diversification In Pharmaceuticals, Hospital Supplies And Allied Fields

Authors: Louis Tuvee, Jean Bigant

June 1, 1973

Rapid impact

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px 'Helvetica Neue'}p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px 'Helvetica Neue'; min-height: 14.0px}Making a new product a market leader in one year through machine learning, psychology, and...

Catalogue: Congress 2019: The Global Data & Insights Summit

Authors: Genevieve Hall, Vivek Banerji, Daniel Rayner, Alessandro D'Angelo, Dan Atkins

Companies: Insight Dojo, Shionogi

September 8, 2019

Sharpening the act

This paper outlines a largely personal view of the challenges facing marketing researchers and their colleagues in pharmaceutical companies and the actions that deserve priority. Preparation of the paper has been assisted by discussions with senior...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: John S. Burton

June 1, 1995

The concept of prescriber scaling of intrinsic drug factors

Intrinsic drug factors consist of all the properties of drugs that determine its clinical profile. There is usually a large amount of clinical data available at the moment of market introduction of a new drug. From these data a clinical profile can...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Erwin A. Douwes, Petra Draaijer

June 1, 1995

Prevalence estimation of selected fungal infections for today and a forecast for the year 2000, covering key countries

Estimations of the potential market volume for new products should be developed from clinical and epidemiological data (number of patients) as a basis, rather applying straightforward estimations of sales volumes. The goals of the study presented...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Sebastian Weil, Arno Brandt

Company: Roche

June 1, 1995

How to optimise the go/no go decisions

This paper will focus on the interchange between the critical commercial and medical functions and the decisions they can make or change as a result of input from key sources of intelligence and experience. Case studies which illustrate the...

Catalogue: EphMRA/ESOMAR Conference 1994: Meeting The Pressures By Intelligent Resourcing

Author: Stuart Cooper

June 1, 1994

Targeting doctors in the Middle East - Is it just a mirage?

This paper will review the segmentation, classification and targeting of doctors within the context of overall promotional activity in the Middle East. Using Saudi Arabia as a specific example, it will discuss current methods and examine their...

Catalogue: ESOMAR Global Healthcare Conference 2003

Author: Jim Ryan

February 23, 2003

Generating market insight

This paper sets the scene for discussion on a crucial topic: 'Is market research enough to provide insight?'.Drawing on their own extensive experience as market researchers and business analysts for the pharmaceutical industry, the authors aim to...

Catalogue: Global Healthcare 2004

Authors: Martine Leroy-Sharman, Susanne West

February 22, 2004

Partners in innovation

This paper addresses innovative online qualitative research with pharmacists across Canada. The paper explores why innovation is crucial to business success and how companies can work together to foster new ideas; how an online methodology yielded...

Catalogue: ESOMAR Worldwide Qualitative Research Conference 2004

Authors: Mike Gadd, Laurie Thompson, Rachelle Deshaies

November 28, 2004